GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

mRNA Editing

pathways : mRNA Editing pathways:

Fullview (zoomIn)


Related Pathways to "mRNA Editing" content :


Related Genes to "mRNA Editing" content :

preload


Related products :

Catalog number Product name Quantity
29-266 ADARB1 is an enzyme responsible for pre-mRNA editing of the glutamate receptor subunit B by site-specific deamination of adenosines. Studies in rat found that this enzyme acted on its own pre-mRNA mol 0.1 mg
E3562h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E3561h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E3560h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E3559h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E3558h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E2466h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E2463h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E3557h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E2464h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
E2465h Human Apolipoprotein B mRNA Editing Enzyme Catalyt 96T
APOBEC3H APOBEC3F Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
APOBEC3G APOBEC3D Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
APOBEC3B APOBEC2 Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2
18-003-43623 Apolipoprotein B mRNA editing enzyme. catalytic polypeptide-like 2 variant - N_A Polyclonal 0.1 mg Protein A
APOBEC3D APOBEC3B Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
APOBEC3C APOBEC3A Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
APOBEC3F APOBEC3C Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
APOBEC3A APOBEC1 Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
APOBEC4 APOBEC3G Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
201-20-0378 APOBEC2{apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2}rabbit.pAb 0.1ml
APOC1 APOBEC3H Gene apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
201-20-6549 APOBEC3G{apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G}mouse.mAb 0.1ml
201-20-0379 APOBEC3C{apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C}rabbit.pAb 0.1ml
201-20-6771 APOBEC3C{apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C}mouse.mAb 0.1ml

Pathways :

WP1862: mRNA Editing
WP906: mRNA processing
WP1142: mRNA processing
WP142: mRNA processing
WP1890: Processing of Capped Intronless Pre-mRNA
WP411: mRNA processing
WP1023: mRNA processing
WP793: mRNA processing
WP123: mRNA processing
WP1861: mRNA Capping
WP1889: Processing of Capped Intron-Containing Pre-mRNA
WP310: mRNA processing
WP529: mRNA processing
WP1229: mRNA processing
WP1789: Binding of RNA by Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs)
WP1863: mRNA Processing
WP2218: sGC
WP467: mRNA processing

Related Genes :

Bibliography :
[31303064] Gene Therapy for Methylmalonic Acidemia: Past, Present, and Future.
[31302752] Efficient base editing by RNA-guided cytidine base editors (CBEs) in pigs.
[31299082] Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
[31289497] Induction of t(11;14) IgH enhancer/promoter- gene translocation using CRISPR/Cas9.
[31281099] Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells.
[31273280] Dual usage of a stage-specific fluorescent reporter system based on a helper-dependent adenoviral vector to visualize osteogenic differentiation.
[31271858] In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance.
[31270214] Adenosine deaminases acting on RNA downregulate the expression of constitutive androstane receptor in the human liver-derived cells by attenuating splicing.
[31267870] The Synergy between CRISPR and Chemical Engineering.
[31255978] RNA delivery biomaterials for the treatment of genetic and rare diseases.